Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood brain barrier. Kim H N, Kim Y R, Ahn S M, Lee S K, Shin H K, Choi B T J Neurochem. 2015 Aug 18. PMID: 26285165. Abstract CommentRecommendBookmarkWatch